Hyperbaric oxygen therapy and the eye.

Frank K Butler3
Estimated H-index: 3
,
Catherine Hagan3
Estimated H-index: 3
,
Heather Murphy-Lavoie4
Estimated H-index: 4
Sources
Abstract
Abstract Hyperbaric oxygen therapy (HBOT) is a primary or adjunctive therapy for a variety of medical disorders including some involving the eye. This paper is the first comprehensive review of HBOT for ocular indications. The authors recommend the following as ocular indications for HBOT: decompression sickness or arterial gas embolism with visual signs or symptoms, central retinal artery occlusion, ocular and periocular gas gangrene, cerebro-rhino-orbital mucormycosis, periocular necrotizing fasciitis, carbon monoxide poisoning with visual sequelae, radiation optic neuropathy, radiation or mitomycin C-induced scleral necrosis, and periorbital reconstructive surgery. Other ocular disorders that may benefit from HBOT include selected cases of ischemic optic neuropathy, ischemic central retinal vein occlusion, branch retinal artery occlusion with central vision loss, ischemic branch retinal vein occlusion, cystoid macular edema associated with retinal venous occlusion, post-surgical inflammation, or intrinsic inflammatory disorders, periocular brown recluse spider envenomation, ocular quinine toxicity, Purtscher's retinopathy, radiation retinopathy, anterior segment ischemia, retinal detachment in sickle cell disease, refractory actinomycotiC lacrimal canaliculitis, pyoderma gangrenosum of the orbit and refractory pseudomonas keratitis. Visual function should be monitored as clinically indicated before, during, and after therapy when HBOT is undertaken to treat vision loss. Visual acuity alone is not an adequate measure of visual function to monitor the efficacy of HBOT in this setting. Ocular examinations should also include automated perimetry to evaluate the central 30 degrees of visual field at appropriate intervals. Interpretation of the literature on the efficacy of HBOT in treating ocular disorders is complicated by several factors: frequent failure to include visual field examination as an outcome measure, failure to adequately address the interval from symptom onset to initiation of HBOT, and lack of evidence for optimal treatment regimens for essentially all ocular indications. Because some ocular disorders require rapid administration of HBOT to restore vision, patients with acute vision loss should be considered emergent when they present. Visual acuity should be checked immediately, including vision with pinhole correction. If the patient meets the criteria for emergent HBOT outlined in the paper, normobaric oxygen should be started at the highest inspired oxygen fraction possible until arrangements can be made for HBOT.
📖 Papers frequently viewed together
2017
44 Citations
54 Citations
References334
Newest
#1Michael H BennettH-Index: 30
#2Jan P LehmH-Index: 6
Last. Jason Wasiak (Monash University)H-Index: 39
view all 4 authors...
Background Decompression illness (DCI) is due to bubble formation in the blood or tissues following the breathing of compressed gas. Clinically, DCI may range from a trivial illness to loss of consciousness, death or paralysis. Recompression is the universally accepted standard treatment of DCI. When recompression is delayed, a number of strategies have been suggested in order to improve the outcome. Objectives To examine the effectiveness and safety of both recompression and adjunctive therapie...
36 CitationsSource
#1Lovre BojićH-Index: 1
#2G RacicH-Index: 1
Last. H KovacevićH-Index: 1
view all 4 authors...
Following the hypothesis that chronic ische- mia is the main cause of functional deficiency in glau- coma, a double blind clinical experiment was carried out to study the effect of hyperbaric oxygenation in 51 glau- coma subjects, of which 31 were in the experimental group and 20 in the control group. In the experimental group there was a significant improvement of visual fields (p 0.05).
15 CitationsSource
#1Halit Oguz (Harran University)H-Index: 13
#2Gungor Sobaci (Military Medical Academy)H-Index: 18
Hyperbaric oxygen therapy is a primary or adjuvant therapeutic method used in treatment of various acute or chronic disorders. Currently, eye diseases are among the off-label use of hyperbaric oxygen. However, there is an increasing body of evidence showing its safety and efficacy in retinal artery occlusion, cystoid macular edema secondary to retinal vein occlusion, scleral thinning and necrosis faced after pterygium surgery, orbital rhino-cerebral mucormycosis, nonhealing corneal edema, and an...
44 CitationsSource
#1Sohan Singh Hayreh (UI: University of Iowa)H-Index: 112
#2M. Bridget Zimmerman (UI: University of Iowa)H-Index: 59
Objective To investigate systematically the natural history of visual outcome in nonarteritic anterior ischemic optic neuropathy (NAION). Design Cohort study. Participants Three hundred forty consecutive untreated patients (386 eyes) with NAION, first seen in our clinic from 1973 to 2000. Methods At first visit, all patients gave a detailed ophthalmic and medical history and underwent a comprehensive ophthalmic evaluation. Visual evaluation was done by recording visual acuity, using the Snellen ...
163 CitationsSource
#1Ashish Agrawal (Manchester Royal Eye Hospital)H-Index: 1
#2Martin McKibbinH-Index: 28
Aims: To study the incidence, systemic associations, presenting features and natural history of Purtscher’s retinopathy in the UK and Ireland. Methods: Cases were collected prospectively by active surveillance through the British Ophthalmological Surveillance Unit. Clinical details were obtained using an incident questionnaire, with follow-up at 1 and 6 months. Results: Clinical details were obtained for 15 cases over 12 months. These were associated with road traffic accidents in 6 cases, chest...
100 CitationsSource
A case of retinal central vein occlusion (CRVO) in a 43-year-old man is presented in which hyperbaric oxygen (HBO2) was used as the only treatment method. CRVO is a relatively common cause of visual loss, with hypertension, diabetes, glaucoma and hypercoagulable conditions identified as risk factors. The patient in this report had none of these risk factors and declined treatments other than hyperbaric oxygen. HBO2 was effective in sustaining the ischemic retina and controlling retinal edema unt...
11 Citations
#1Sohan Singh Hayreh (UI: University of Iowa)H-Index: 112
#2M. Bridget Zimmerman (UI: University of Iowa)H-Index: 59
Objective To describe the clinical entity of incipient nonarteritic anterior ischemic optic neuropathy (NAION). Design Cohort study. Participants Fifty-four patients (60 eyes) seen in our clinic from 1973 through 2000. Methods At their first visit to our clinic, all patients gave a detailed ophthalmic and medical history and underwent a comprehensive ophthalmic evaluation, color fundus photography, and fluorescein fundus angiography. At each follow-up visit (of 49 patients [55 eyes]), the same o...
73 CitationsSource
#1Lindell K. Weaver (Intermountain Healthcare)H-Index: 42
#2Karen J. ValentineH-Index: 2
Last. Ramona O. HopkinsH-Index: 78
view all 3 authors...
acutely CO-poisoned patients more than 15 years of age. Patients eligible but not enrolled in the randomized trial, and not receiving HBO2, were followed during the study interval. In patients not receiving HBO2, we performed univariate analyses including risk factors identified by randomized trial subgroup analyses. A multivariable analysis was performed using univariate results with and without HBO2. Measurements and Main Results: In 163 patients not receiving HBO2, 68 (42%) manifested sequela...
167 CitationsSource
#2Lucia SobrinH-Index: 33
Last. C. Stephen FosterH-Index: 104
view all 5 authors...
Purpose To evaluate the short-term safety and efficacy of intravitreal bevacizumab for the treatment of cystoid macular edema (CME) secondary to uveitis. Design Retrospective, noncomparative, interventional case series. Participants Thirteen patients undergoing treatment for recalcitrant uveitic macular edema at one referral center. Methods Charts of patients who received one 2.5-mg intravitreal injection of bevacizumab in one eye were reviewed for clinical information including best-corrected S...
119 CitationsSource
Objective To evaluate intravitreal bevacizumab for radiation retinopathy. Methods After plaque radiation therapy, 6 patients developed radiation retinopathy (retinal edema, hemorrhages, microangiopathy, and neovascularization). Intravitreal bevacizumab (1.25 mg in 0.05 mL) was periodically injected (every 6-8 weeks). Ophthalmic evaluations included visual acuity, ophthalmic examination, fundus photography, fluorescein angiography, and optical coherence tomography/scanning laser ophthalmoscopy (O...
100 CitationsSource
Cited By29
Newest
#1Yehudit Bloch (Israel Ministry of Health)H-Index: 1
#2Robert H. Belmaker (BGU: Ben-Gurion University of the Negev)H-Index: 81
Last. Abed N. Azab (BGU: Ben-Gurion University of the Negev)H-Index: 10
view all 7 authors...
Oxygen enriched air may increase oxygen pressure in brain tissue and have biochemical effects even in subjects without lung disease. Consistently, several studies demonstrated that normobaric oxygen treatment has clinical benefits in some neurological conditions. This study examined the efficacy of normobaric oxygen treatment in subjects with depression. In a randomized, double-blind trial, 55 participants aged 18–65 years with mild to moderate depression (had a Hamilton Rating Scale for Depress...
Source
Source
#1Somya Chowdhary (Bascom Palmer Eye Institute)H-Index: 1
#2Vivek SawhneyH-Index: 1
Last. Shailesh K GuptaH-Index: 1
view all 5 authors...
Objective To describe a case of central retinal artery occlusion (CRAO) after nasosinal surgery and subject's subsequent response to hyperbaric oxygen therapy (HBOT). Design Observational case report. Results We describe a subject with diagnosed CRAO after septoplasty, bilateral inferior turbinate reduction and balloon sinuplasty, who was given hyperbaric oxygen treatment after four days of onset of CRAO with an improvement in visual acuity and visual field. Conclusion Even though CRAO has been ...
Source
#1Tom Shokri (Penn State Milton S. Hershey Medical Center)H-Index: 5
#2Weitao WangH-Index: 6
Last. Yadranko DucicH-Index: 11
view all 6 authors...
The implementation of radiotherapy in the multimodal treatment of advanced head and neck cancer has greatly improved survival rates. In some patients, however, this benefit comes at the potential expense of the tissue surrounding the primary site of malignancy. Osteoradionecrosis (ORN) of the facial bones, in particular the maxilla, is a debilitating complication of radiation therapy. Exposure to ionizing radiation results in devitalization of underlying bone with necrosis of adjacent soft tissu...
1 CitationsSource
#1Ilka Schmidt (RWTH Aachen University)H-Index: 1
#2Peter Walter (RWTH Aachen University)H-Index: 135
Last. David Kuerten (RWTH Aachen University)H-Index: 9
view all 7 authors...
Nonperfusion of retinal tissue due to arterial occlusion leads inevitably to mostly irreversible retinal damage. Until today no evidence-based treatment exists. Inhalation of 100% oxygen at high atmospheric pressure causes an increased solubility of oxygen in the blood that helps the retinal tissue to survive through diffusion in case of an artery occlusion till vascular recanalization occurs. Hence the purpose of this study is to compare the visual outcome in patients with retinal branch artery...
1 CitationsSource
AIM To evaluate baseline foveal disorganisation of retinal inner layers (DRIL) as a prognostic factor in eyes with central retinal artery occlusion (CRAO).
4 CitationsSource
#1Thijs T. Wingelaar (Royal Netherlands Navy)H-Index: 5
#2Pieter-Jan A. M. van Ooij (Royal Netherlands Navy)H-Index: 5
Last. Rob A. van HulstH-Index: 7
view all 3 authors...
In Special Operations Forces (SOF) closed-circuit rebreathers with 100% oxygen are commonly utilised for covert diving operations. Exposure to high partial pressures of oxygen (PO2) could cause damage to the central nervous system and pulmonary system. Longer exposure time and higher PO2 leads to faster development of more serious pathology. Exposure to a PO2 above 1.4 ATA can cause central nervous system toxicity, leading to a wide range of neurologic complaints including convulsions. Pulmonary...
14 CitationsSource
#1Andreia SoaresH-Index: 1
#2Nuno GomesH-Index: 8
Last. Carla FerreiraH-Index: 20
view all 4 authors...
Central retinal artery occlusion (CRAO) is an ophthalmological emergency. Various treatment modalities have been tried, but none have shown to alter natural history of the disease. Hyperoxia can restore retinal oxygenation, and favourable results were obtained with hyperbaric oxygen therapy (HBOT). We report two patients with sudden visual loss due to CRAO treated with HBOT. Case 1: a 61-year-old female, presented with CRAO in her left eye(OS). She was submitted to eight sessions of HBOT(2.4atmo...
7 CitationsSource
2 CitationsSource
#1Robert A. Linsenmeier (NU: Northwestern University)H-Index: 38
#2Hao Zhang (NU: Northwestern University)H-Index: 68
Abstract This article discusses retinal oxygenation and retinal metabolism by focusing on measurements made with two of the principal methods used to study O 2 in the retina: measurements of PO 2 with oxygen-sensitive microelectrodes in vivo in animals with a retinal circulation similar to that of humans, and oximetry, which can be used non-invasively in both animals and humans to measure O 2 concentration in retinal vessels. Microelectrodes uniquely have high spatial resolution, allowing the ma...
94 CitationsSource